Asthma Management Articles & Analysis
58 news found
Asthma and Allergy Awareness Month is just a few weeks away, and this year, the 6th of May is recognized as World Asthma Day. The month of May is dedicated to asthma control and education to increase awareness about the disease and how those with it can prevent or mitigate exposures to asthma triggers, allergens, and respiratory ...
Bedfont® Scientific Ltd., world leaders in breath analysis with over 47 years of knowledge in designing and manufacturing medical breath analysis devices, welcomes the recent update to the National Institute for Health and Care Excellence (NICE) guidelines on asthma management. Bedfont® manufactures the NObreath® Fractional exhaled Nitric Oxide (FeNO) ...
Spirometry and FeNO present physicians with complementary diagnostic data to inform asthma care pathways. NIOX VERO® is non-invasive, simple-to-use, and provides rapid standardised FeNO measurements. ...
There are many known asthma triggers, but one of the more common ones is exposure to elevated levels of mold. This information is important for asthmatics, especially those living in Puerto Rico which has some of the highest asthma rates in the United States. Across the entire country, asthma caused 5.8 million physician office visits and 1.6 ...
In extreme cases, it can even result in death. To help spread awareness of asthma and allergies, and steps people can take to manage their condition and prevent new cases, the month of May is recognized as Asthma and Allergy Awareness Month. “This is no cure for asthma, but it can be managed with medical ...
The New York State Department of Health (NYSDOH) reports that in at least one out of every six asthmatics, their condition is caused or made worse by workplace exposures. Occupational asthma, also referred to as work-related asthma, can dramatically impact a person’s quality of life, reduce productivity, and increase costs. ...
Occupational asthma, also known as work-related asthma, can dramatically impact a worker’s quality of life and reduce their productivity. ...
” Challenge #1: Leverage data to proactively identify “rising risk” beneficiaries managed by TC2 using predictive modeling in order to avoid or minimize major healthcare episodes. Challenge #2: Use technology to keep children and teens in Middle Georgia out of the ER by promoting self-management of their asthmatic medication. The finalists ...
Ian Johnson, Circassia’s Executive Chairman, said: “As a Board and Management team, we conducted a strategic review of our business and its prospects, concluding that it would be in the best interests of both patients and our shareholders for us to terminate the development and commercialisation agreement between the Company and AstraZeneca UK Limited for the U.S. ...
The Journal of Asthma published the results of a study that assessed asthma patients and their ability to perform high-quality daily spirometry with the AioCare system. The study has shown that home spirometry is safe without supervision and feasible for asthma patients. Abstract: Background: Self-management is an appealing ...
ByAioCare
The Company sells its market-leading NIOX® asthma management products directly to specialists in the United States, United Kingdom, China, Germany and Italy, and in a wide range of other countries through its network of partners. ...
Abionic SA, the developer of proprietary disruptive nanotechnology based rapid diagnostic solutions, and Genentech, a member of the Roche Group, announced today a strategic agreement to develop and provide an In Vitro Diagnostic (IVD) Asthma Test Panel using Abionic’s POC abioSCOPE® platform in the United States. Abionic’s POC abioSCOPE®, a compact, ultra-fast medical device ...
As COO he will further strengthen Circassia’s commercial focus and lead the Company’s global commercial strategy and operational management. He will also join the Company’s Board as an Executive Director when he joins Circassia on 2 September 2019. ...
The Company sells its market-leading NIOX® asthma management products directly to specialists in the United States, United Kingdom, China and Germany, and in a wide range of other countries through its network of partners. ...
The Company sells its novel, market-leading NIOX® asthma management products directly to specialists in the United States, United Kingdom, China and Germany, and in a wide range of other countries through its network of partners. ...
In addition to receiving the economic benefits of Tudorza®’s commercialisation, the Company will have further flexibility in managing the composition of its sales force, customer targeting, product detail prioritisation, territory definition, distribution strategy, pricing and market access priorities. ...
Circassia sells its novel, market-leading NIOX® asthma management products directly to specialists in the United States, United Kingdom and Germany, and in a wide range of other countries through its network of partners. ...
Circassia sells its novel, market-leading NIOX® asthma management products directly to specialists in the United States, United Kingdom and Germany, and in a wide range of other countries through its network of partners. ...
Circassia sells its novel, market-leading NIOX® asthma management products directly to specialists in the United States, United Kingdom and Germany, and in a wide range of other countries through its network of partners. ...
As recently as 2015, the agency reports that 1 in 12 children had asthma. Asthma is a long-term, inflammatory disease that causes the airways of the lungs to tighten and constrict, leading to wheezing, breathlessness, chest tightness and coughing. ...